Christopher Junker is the group head of Life Science for BAT and is responsible for the company’s global science program for smokeless products and its science engagement plan. Junker first joined the company in 2011 and was responsible for regulatory strategy and engagement, leading a multidisciplinary team of scientists and regulatory experts in the synthesis of premarket regulatory submissions for Reynolds’ vapor and oral tobacco product portfolios. He is ultimately passionate about the company’s purpose to build “a better tomorrow,” and is excited to do his part in delivering tobacco harm-reduction by helping adult smokers, who would otherwise continue to smoke, to switch from cigarettes to reduced-risk alternatives.